224 related articles for article (PubMed ID: 18343002)
1. Management of viral hepatitis in hematologic malignancies.
Firpi RJ; Nelson DR
Blood Rev; 2008 May; 22(3):117-26. PubMed ID: 18343002
[TBL] [Abstract][Full Text] [Related]
2. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
[TBL] [Abstract][Full Text] [Related]
3. Viral hepatitis: manifestations and management strategy.
Firpi RJ; Nelson DR
Hematology Am Soc Hematol Educ Program; 2006; ():375-80. PubMed ID: 17124086
[TBL] [Abstract][Full Text] [Related]
4. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
5. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies.
Lalazar G; Rund D; Shouval D
Br J Haematol; 2007 Mar; 136(5):699-712. PubMed ID: 17338776
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
[TBL] [Abstract][Full Text] [Related]
8. [Effect of lamivudine for hepatitis B virus reactivation in blood cancer patients undergoing immunosuppressive chemotherapy].
Sugimoto R; Enjoji M; Kotoh K; Noguchi K; Tsuruta S; Nakamuta M; Nawata H
Fukuoka Igaku Zasshi; 2004 Oct; 95(10):274-9. PubMed ID: 15678886
[TBL] [Abstract][Full Text] [Related]
9. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
[TBL] [Abstract][Full Text] [Related]
10. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
Chehadeh W; Al-Nakib W
J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
[TBL] [Abstract][Full Text] [Related]
11. [Prevention and therapy of reactivation of hepatitis B in immunosuppressed patients].
von Wagner M; Zeuzem S
Dtsch Med Wochenschr; 2009 Feb; 134(6):255-8. PubMed ID: 19180418
[TBL] [Abstract][Full Text] [Related]
12. Chronic viral hepatitis and chronic kidney disease.
Chacko EC; Surrun SK; Mubarack Sani TP; Pappachan JM
Postgrad Med J; 2010 Aug; 86(1018):486-92. PubMed ID: 20709771
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the risk of hepatitis B reactivation in patients with haematological malignancies: is the serum hepatitis B virus profile reliable?
Ferraro D; Pizzillo P; Di Marco V; Vultaggio A; Iannitto E; Venezia G; Craxì A; Di Stefano R
Liver Int; 2009 Sep; 29(8):1171-7. PubMed ID: 19602139
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes.
Chevaliez S; Pawlotsky JM
Best Pract Res Clin Gastroenterol; 2008; 22(6):1031-48. PubMed ID: 19187865
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
[TBL] [Abstract][Full Text] [Related]
16. [Features of combined (HBV/HCV-infection) viral lesion of the liver].
Maev IV; Nikushkina IN; Samsonov AA; Aksel'rod AG
Ter Arkh; 2008; 80(2):57-61. PubMed ID: 18372598
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C treatment concomitant to chemotherapy as "salvage" therapy in children with hematologic malignancies.
Papaevangelou V; Varsami M; Papadakis V; Zellos A; Parcharidou A; Papargyri S; Karentzou O; Manolaki N; Roma E; Polychronopoulou S
Pediatr Infect Dis J; 2010 Mar; 29(3):277-80. PubMed ID: 19949358
[TBL] [Abstract][Full Text] [Related]
18. Management of patients co-infected with HBV and HCV.
Coffin CS; Terrault NA
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):549-58. PubMed ID: 19485795
[TBL] [Abstract][Full Text] [Related]
19. Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta-analysis.
Paul S; Dickstein A; Saxena A; Terrin N; Viveiros K; Balk EM; Wong JB
Hepatology; 2017 Aug; 66(2):379-388. PubMed ID: 28128861
[TBL] [Abstract][Full Text] [Related]
20. Management of chronic hepatitis B in children.
Shah U; Kelly D; Chang MH; Fujisawa T; Heller S; González-Peralta RP; Jara P; Mieli-Vergani G; Mohan N; Murray KF
J Pediatr Gastroenterol Nutr; 2009 Apr; 48(4):399-404. PubMed ID: 19322053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]